{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:14:19Z","timestamp":1790741659801,"version":"4.1.0"},"reference-count":37,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Ministry of University and Research ITALY","award":["#NEXTGENERATIONEU (NGEU) and funded by the Ministr"],"award-info":[{"award-number":["#NEXTGENERATIONEU (NGEU) and funded by the Ministr"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cephalalgia"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People with high-frequency episodic migraine or chronic migraine may have resistant or refractory forms. The lack of efficacy of pharmacologic therapies is a major clinical challenge that requires alternative strategies, including neuromodulation and exploration of new targets to improve disease management. The present study aimed to test the effectiveness of an accelerated protocol of theta burst stimulation (iTBS) via the dorso lateral prefrontal cortex (DLPFC) in a group of chronic migraine individuals who did not respond to monoclonal antibodies against calcitonin gene-related peptide (CGRP). The co-primary outcomes were the reduction in monthly headache frequency, use of symptomatic medication and perceived pain intensity. In parallel we wanted to understand the possible role of the prefrontal cortex in the emotional and cognitive functions likely responsible for treatment failure and to offer a possible non-pharmacologic option to individuals with difficult-to-treat migraine. To this end, we measured clinical outcomes along with an electroencephalogram (EEG) and behavioral responses to cognitive and emotional tests related to prefrontal functions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study was conducted in a controlled, single-blind design in 12 people with chronic refractory migraine. An accelerated protocol of iTBS on DLPFC was preceded by a sham session and followed by a two-month follow-up. Clinical data were collected and a neuropsychological assessment including anxiety, depression and cognitive profile was performed. Cognitive and emotional Stroop testing was performed at baseline, after sham and real stimulation, and at follow-up during high-density EEG recording to obtain event-related potentials (N2, N400 and late sustained potential (LP)). Stroop data from an age- and sex-matched control group were compared with those of migraine individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Monthly headache days, monthly medication days and headache intensity improved after real stimulation. A similar trend emerged for anxiety, depression, and cognitive performance. The Stroop test was impaired in the baseline, as evidenced by an increase in reaction time and a decrease in N2 and LP in the cognitive task, which returned to normal after real iTBS and at follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results support the efficacy of iTBS as a non-invasive neuromodulation approach for the treatment of chronic, refractory migraine. They tentatively point to the role of cognitive fog and psychopathological symptoms in refractoriness to anti-CGRP drugs, which should be confirmed in larger multicenter studies, and suggest this non-pharmacological approach as another promising therapeutic option for people with difficult-to-treat migraine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03331024251364843","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:38:12Z","timestamp":1758134292000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Dorso lateral prefrontal cortex stimulation with TMS in chronic migraine individuals refractory to anti-CGRP monoclonal antibodies: Clinical, neuropsychological and neurophysiological effects"],"prefix":"10.1177","volume":"45","author":[{"given":"Livio","family":"Clemente","sequence":"first","affiliation":[{"name":"Bari Aldo Moro University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Paparella","sequence":"additional","affiliation":[{"name":"Bari Aldo Moro University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Scannicchio","sequence":"additional","affiliation":[{"name":"Bari Aldo Moro University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Abbatantuono","sequence":"additional","affiliation":[{"name":"Bari Aldo Moro University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"Tancredi","sequence":"additional","affiliation":[{"name":"Bari Aldo Moro University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuella","family":"Ladisa","sequence":"additional","affiliation":[{"name":"Bari Aldo Moro University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna D.","family":"Delussi","sequence":"additional","affiliation":[{"name":"Bari Aldo Moro University"},{"name":"ForPsiCom Department, Bari Aldo Moro University, Bari, Apulia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ammendola","sequence":"additional","affiliation":[{"name":"Bari Aldo Moro University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addolorata Maria Pia","family":"Prudenzano","sequence":"additional","affiliation":[{"name":"Policlinico General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6567-5373","authenticated-orcid":false,"given":"Marina","family":"de Tommaso","sequence":"additional","affiliation":[{"name":"Bari Aldo Moro University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"e_1_3_2_2_2","first-page":"174480691876769","article-title":"Chronic migraine: a process of dysmodulation and sensitization","volume":"14","author":"Su M","year":"2018","unstructured":"Su M, Yu S. Chronic migraine: a process of dysmodulation and sensitization. Mol Pain [Internet] 2018 [cited 2025 Feb 21]; 14: 1744806918767697. Available from: https:\/\/journals.sagepub.com\/doi\/10.1177\/1744806918767697","journal-title":"Mol Pain [Internet]"},{"key":"e_1_3_2_3_2","article-title":"Aberrant interactions of cortical networks in chronic migraine: A resting-state fMRI study","volume":"92","author":"Coppola G","year":"2019","unstructured":"Coppola G, Di Renzo A, Petolicchio B, et al. Aberrant interactions of cortical networks in chronic migraine: A resting-state fMRI study. Neurology [Internet] 2019 [cited 2025 Feb 21]; 92. Available from: https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0000000000007577","journal-title":"Neurology [Internet]"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.14419"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Karimi L Wijeratne T Crewther SG et al. The migraine-anxiety comorbidity among migraineurs: a systematic review. Front Neurol [Internet] 2021 [cited 2025 Feb 23]; 11: 613372. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.613372\/full","DOI":"10.3389\/fneur.2020.613372"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/2515816320951136"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0003-1"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-823357-3.00024-0"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-023-01183-6"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01130-5"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104943"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2008.01157.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-1040-x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2024.07.011"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sc.2016.87"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2024.12.015"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01839-5"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-15-64"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0333-1024.2001.00277.x"},{"key":"e_1_3_2_20_2","volume-title":"BDI-II: beck depression inventory-II\u202f: manuale","author":"Beck AT","year":"2008","unstructured":"Beck AT, Steer RA, Brown GK, et al. BDI-II: beck depression inventory-II\u202f: manuale. Firenze: OS, 2008."},{"key":"e_1_3_2_21_2","volume-title":"Leading-edge psychological tests and testing research","author":"Lange MA","year":"2007","unstructured":"Lange MA (ed.) Leading-edge psychological tests and testing research. New York: Nova Science Publishers, 2007, 213 p."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8260.1967.tb00530.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/08919887241227404"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01997792"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-012-1130-x"},{"key":"e_1_3_2_26_2","unstructured":"Smith A. Symbol Digit Modalities Test [Internet]. 2016 [cited 2025 Feb 27]. Available from: https:\/\/doi.apa.org\/doi\/10.1037\/t27513-000"},{"key":"e_1_3_2_27_2","volume-title":"Standardizzazione e taratura italiana di test neuropsicologici\u202f: gruppo italiano per lo studio neuropsicologico dell\u2019invecchiamento","author":"Spinnler H","year":"1987","unstructured":"Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici\u202f: gruppo italiano per lo studio neuropsicologico dell\u2019invecchiamento. Milano: Masson Italia periodici, 1987, Italian journal of neurological sciences., Supplementum."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bandc.2020.105637"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpsycho.2006.10.002"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00285-1"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01187-2"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpsycho.2010.12.003"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12512-z"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2004.08.008"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231189751"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241313377"},{"key":"e_1_3_2_37_2","article-title":"Cognitive reserve and well-being in migraine patients: a multidimensional approach to migraine assessment in an Italian tertiary headache center","volume":"34","author":"Paparella G","year":"2024","unstructured":"Paparella G, Abbatantuono C, Clemente L, et al. Cognitive reserve and well-being in migraine patients: a multidimensional approach to migraine assessment in an Italian tertiary headache center. Confinia Cephalal [Internet] 2024 [cited 2025 Feb 26]; 34. Available from: https:\/\/www.confiniacephalalgica.com\/site\/article\/view\/15769","journal-title":"Confinia Cephalal [Internet]"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2023.12.004"}],"container-title":["Cephalalgia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03331024251364843","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03331024251364843","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03331024251364843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:47:05Z","timestamp":1777387625000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03331024251364843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1177\/03331024251364843"],"URL":"https:\/\/doi.org\/10.1177\/03331024251364843","relation":{},"ISSN":["0333-1024","1468-2982"],"issn-type":[{"value":"0333-1024","type":"print"},{"value":"1468-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"article-number":"03331024251364843"}}